Crescent Biopharma, Inc. (CBIO)

NASDAQ: CBIO · Real-Time Price · USD

13.06

-0.02 (-0.15%)

At close: Nov 21, 2025, 4:00 PM EST

12.80

-0.26 (-1.99%)

After-hours: Nov 21, 2025, 5:18 PM EST

Crescent Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024
Period Ending	Nov '25 Nov 21, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-3.26	-3.26
Quick Ratio	3.62	3.62
Current Ratio	3.62	3.62
Return on Capital Employed (ROCE)	-264.40%	-264.40%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q